NJ Angel Investor Program Invests $125M In Tech Companies

Technology and biotechnology companies around New Jersey invested more than $51 million in 2015.


https://businessfacilities.com/2016/02/nj-angel-investor-tax-credit-program-injects-125m-in-tech-companies/
Technology and biotechnology companies around New Jersey invested more than $51 million in 2015.
Facebooktwittergoogle_plusredditpinterestlinkedintumblrmail

NJ Angel Investor Tax Credit Program Injects $125M In Tech Companies

NJ Angel Investor Program Invests $125M In Tech Companies

More than $125 million has been invested in New Jersey-based emerging technology and biotechnology businesses through the state’s Angel Investor Tax Credit Program since its inception in 2013. Administered by the New Jersey Economic Development Authority (EDA) in consultation with the New Jersey Division of Taxation, the program approved 213 investments in 2015, representing more than $51 million of private capital investment into two dozen companies.

NJ Angel Investor Tax Credit Program.
Source: TAXIS Pharmaceuticals

“We continue to hear from entrepreneurs and investors alike how vital the Angel Investor Tax Credit Program is to growing technology and biotechnology companies around the state,” said EDA Chief Executive Officer Melissa Orsen. “New Jersey has one of the most competitive programs in the nation and the results to date show that it is helping us attract private capital from across the globe.”

Investors represented 18 states including New York, Massachusetts, Connecticut, Maryland and California; and six countries, including China, Australia, and Hong Kong, added Orsen.

In 2015, Angel Investor Tax Credit investments of more than $51 million were approved for 28 companies in New Jersey’s technology, clean technology and biotechnology sectors.  These include Bedminster-based technology startup STOPit, which creates software to enable smartphone users to report incidents of bullying; telecommunications provider D3 Unified Communications, located in Newark; and Monmouth Junction biotechnology business Taxis Pharmaceuticals, which seeks to discover and develop pharmaceuticals targeting multidrug-resistant bacterial infections.

The program offers a 10 percent refundable tax credit against New Jersey corporation business or gross income tax for qualified investments in an emerging technology business with a physical presence in New Jersey and that conducts research, manufacturing, or technology commercialization in the state. The program is available to all eligible taxpayers, including out-of-state investors.

New Jersey’s EDA is part of the state’s results-driven Partnership for Action, which is the hub for all economic development activity in New Jersey and is comprised of four interconnected and highly focused organizational elements: Choose New Jersey, the Business Action Center, the Office of the Secretary of Higher Education and the EDA.

Relocating or Expanding Your Business In New Jersey

Considering New Jersey for your company’s relocation or expansion project? Check out Business Facilities’ New Jersey Incentives and Workforce Development Guide.

 

Suggested Links:

You Might Like:

LEAVE A REPLY